Cargando…
A Unique Case of IGF-2 Induced Hypoglycemia Associated with Hepatocellular Carcinoma
Tumor-induced hypoglycemia (TIH) associated with hepatocellular carcinoma (HCC) results from tumor production of insulin-like growth factor 2 (IGF-2), resulting in recurrent hypoglycemia. Serum levels of insulin-like growth factor 1 (IGF-1), insulin-like growth factor 2 (IGF-2), or pro-insulin-like...
Autores principales: | Rana, Prachi, Kim, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815553/ https://www.ncbi.nlm.nih.gov/pubmed/31737377 http://dx.doi.org/10.1155/2019/4601484 |
Ejemplares similares
-
SAT159 A Unique Case Of IGF-2 Induced Hypoglycemia As First Manifestation Of Hepatocellular Carcinoma
por: Ali, Israa, et al.
Publicado: (2023) -
Overexpression of IGF2 and IGF2 receptor in malignant solitary fibrous tumor with hypoglycemia: a case report
por: Arakawa, Yusuke, et al.
Publicado: (2018) -
Early Improvement of Non-islet Cell Tumor Hypoglycemia by Chemotherapy Using Lenvatinib in a Case with Type 2 Diabetes and Hepatocellular Carcinoma Producing Big IGF-II
por: Izutsu, Takuma, et al.
Publicado: (2020) -
Isolated Hypomethylation of IGF2 Associated with Severe Hypoglycemia Responsive to Growth Hormone Treatment
por: Grünert, Sarah C., et al.
Publicado: (2021) -
Intractable Fasting Hypoglycemia as a Manifestation of Hepatocellular Carcinoma
por: Forde, Justin J., et al.
Publicado: (2017)